Readystate Asset Management »

Vaxcyte shares owned by Readystate Asset Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Readystate Asset Management from 13F filings

Historical chart of Readystate Asset Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Readystate Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Readystate Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.1M 132k 46.14
2025-06-30 $1.2M 36k 32.51
2023-09-30 $3.0M 59k 50.98
2023-06-30 $2.8M 56k 49.94

More positions owned by Readystate Asset Management

Ishares Tr Core S&p500 Etf (IVV)
Rivian Automotive Note 3.625%10/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Mirum Pharmaceuticals Note 4.000% 5/0 (Principal)
Hershey Company (HSY)
Cyberark Software SHS (CYBR)
Centrus Energy Corp Note 2.250%11/0 (Principal)
Transmedics Group Note 1.500% 6/0 (Principal)
Bristol Myers Squibb (BMY)
Soleno Therapeutics (SLNO)
Immunome (IMNM)
Rivian Automotive Com Cl A Put Option (RIVN)
Bentley Sys Note 0.375% 7/0 (Principal)
Wisdomtree Note 3.250% 8/1 (Principal)
Lantheus Hldgs Note 2.625%12/1 (Principal)

View all positions for Readystate Asset Management

Top funds holding Vaxcyte

Henderson Group
FMR
Vanguard Group
RA Capital Management
T. Rowe Price Investment Management
BlackRock
Wellington Management Company
State Street Corporation
D. E. Shaw & Co
Paradigm Biocapital Advisors
Deep Track Capital
Westfield Capital Management Company
Kynam Capital Management
Geode Capital Management
Caligan Partners

View all funds holding Vaxcyte